Peptides for Fat Loss & Metabolic Research

Home/Collections/Peptides for Fat Loss & Metabolic Research

Research-Grade Peptides

Fat Loss & Metabolic Research

Peptides for Fat Loss & Metabolic Research

Peptides for fat loss are compounds studied for how the body regulates appetite, energy expenditure and the breakdown of stored fat. This category groups the four compounds in the Purist range most referenced in metabolic and body-composition research, each acting on a different pathway — receptor signalling, mitochondrial output, growth-hormone release or direct lipolysis.

99%+ Verified Purity
Independent HPLC Assay
Third-Party Lab Tested
Lyophilised & Sealed

View the 4 compounds How to choose

Purist Peptides research vials for fat loss research

4Compounds in category

99%+Minimum verified purity

HPLCIndependent assay method

3Published COAs in category

99%+ PurityThird-Party Lab TestedCOA AvailableSecure Packaging

Retatrutide

R 2,000

MOTS-C

R 750

Tesamorelin

R 2,800

Sold out

AOD 9604

R 750

Mechanisms

The four mechanisms studied in fat-loss research

Fat metabolism is not a single pathway, which is why the compounds here are rarely interchangeable. Retatrutide acts on three receptors at once (GLP-1, GIP and glucagon) and is studied for appetite regulation and energy expenditure. MOTS-C is a mitochondrial-derived peptide investigated for AMPK activation and mitochondrial fat oxidation. Tesamorelin is a GHRH analogue with the strongest body of research around visceral adipose tissue specifically. AOD-9604 is a modified fragment of the growth-hormone molecule studied for lipolysis signalling without broad endocrine stimulation.

Purist Peptides research compounds in a laboratory setting

Study design

Visceral versus subcutaneous fat

Research distinguishes visceral fat — the deep abdominal fat surrounding the organs — from subcutaneous fat stored under the skin. This matters when selecting a compound: Tesamorelin is referenced specifically in visceral-fat models, while Retatrutide and AOD-9604 are studied across broader body-composition endpoints. Study design typically holds nutrition, sleep and activity constant, because compounds of this class are investigated as one variable within a protocol rather than as substitutes for those inputs.

The range

Compounds in this category

The compounds grouped here, each with the pathway it is studied for and the protocol shape most often used.

Retatrutide

Triple-receptor agonist

A triple-receptor agonist (GLP-1 / GIP / glucagon) studied for appetite control, glucose homeostasis and energy expenditure. Published test reports available for both 30 mg and 60 mg presentations.

Typical research cycles run 12–24 weeks with weekly administration and gradual titration

View Retatrutide

MOTS-C

Mitochondrial / AMPK

A mitochondrial-derived peptide investigated for AMPK activation, insulin sensitivity and mitochondrial fat oxidation.

Studied at 2–5 mg, 2–3× weekly over 6–8 weeks; a non-stimulant route to metabolic signalling

View MOTS-C

Tesamorelin

GHRH analogue

A GHRH analogue whose best-documented research application is abdominal and visceral fat reduction, typically 1 mg nightly over 8–12 weeks, with lean-mass preservation as a secondary endpoint

View Tesamorelin

AOD-9604

Lipolysis fragment

A modified peptide fragment studied for lipolysis and fat metabolism without broad endocrine or growth-hormone stimulation.

Researched at 250–500 mcg daily, often fasted, over 8–12 weeks

View AOD-9604

Selection

How to choose

Start from the research question, not the compound name.

If the research question is…	Start with
Appetite and intake is the research question	Retatrutide
Cellular energy and metabolic efficiency	MOTS-C
Visceral/abdominal fat specifically	Tesamorelin
Lipolysis without endocrine stimulation	AOD-9604

Pre-paired

Stacks built on this category

Complete research cycles — every vial needed for the full protocol, 10% below buying the vials separately.

Fat Loss StackRetatrutide + MOTS-C — complete 8-week cycle, 3 vials.View the stack Visceral Fat StackRetatrutide + Tesamorelin — complete 8-week cycle, 3 vials.View the stack Metabolic Reset StackRetatrutide + NAD+ + MOTS-C — complete 8-week cycle, 7 vials.View the stack

Independent laboratory testing of Purist Peptides research compounds

Verified quality

Tested before it ships

Published third-party test reports for Retatrutide 30 mg, Retatrutide 60 mg, Tesamorelin, MOTS-C and AOD-9604 · minimum 99% verified purity · lyophilised powder, refrigerate 2–8 °C after reconstitution · full reconstitution and syringe-measurement guidance on every product page. See Quality Standards.

Retatrutide 30 mg98.81% · COA PDF MOTS-C 10 mg99.11% · COA PDF Tesamorelin 20 mg99.30% · COA PDF

See Quality Standards & all COAs

Questions

Fat Loss research FAQ

Which fat-loss peptide is studied for appetite versus metabolism?

Retatrutide is referenced for appetite signalling through GLP-1, GIP and glucagon receptors. MOTS-C is studied for mitochondrial output and AMPK activation. Tesamorelin targets visceral fat via the growth-hormone axis, and AOD-9604 is studied for direct lipolysis.

What is the difference between Retatrutide and Tesamorelin?

They act on entirely separate systems. Retatrutide is a triple-receptor agonist studied for appetite and energy balance; Tesamorelin is a GHRH analogue studied specifically for visceral adipose tissue. Researchers modelling deep abdominal fat use Tesamorelin; those modelling intake and satiety use Retatrutide.

How long is a typical fat-loss research cycle?

It varies by compound. Retatrutide protocols commonly run 12–24 weeks with weekly titration; Tesamorelin and AOD-9604 typically 8–12 weeks; MOTS-C 6–8 weeks with a 2–4 week break. Exact protocols are documented on each product page.

Do these compounds work without diet and training controls?

Fat-loss research does not treat them that way. Credible study models hold nutrition, sleep and activity constant so the compound is the measured variable — the fundamentals remain part of the protocol, not something the compound replaces.

How is purity verified for these compounds?

Every batch is independently third-party assayed to a minimum of 99% purity. Published test reports exist for Retatrutide (30 mg and 60 mg), Tesamorelin, MOTS-C and AOD-9604, and batch certificates of analysis are on each product page.

Keep exploring